Healthcare • Biotechnology
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if CGEN is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
16 top institutions tracked
Last 13F trend: distributing (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 1
83 filers reported a long position in CGEN for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | $6.8M | 3.2M | -4% |
| RENAISSANCE TECHNOLOGIES LLC | $4M | 1.9M | +15% |
| MORGAN STANLEY | $2.3M | 1.1M | -0.1% |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $2.2M | 1M | Unchanged |
| Taylor Frigon Capital Management LLC | $1.8M | 842.2K | -0.7% |
| ARK Investment Management LLC | $1.7M | 786.5K | -25.1% |
| Altshuler Shaham Ltd | $1.1M | 521.6K | +12,940.6% |
| TWO SIGMA INVESTMENTS, LP | $1.1M | 512.4K | -1.8% |
| STATE STREET CORP | $889.5K | 415.7K | +0.1% |
| Atom Investors LP | $649.5K | 303.5K | +569% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.